Other Organic Chemical terms — page 5 | HESTIA Glossary

Browse all 10,014 other organic chemical terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

(2S)-2-Methyl-1-nitrosopiperidine S(+)-2-METHYL-N-NITROSOPIPERIDINE; (2S)-2-methyl-1-nitrosopiperidine; S(+)-N-Nitroso-2-methylpiperidine; S(+)-N-Nitroso-alpha-pipecoline; Piperidine, 2-methyl-N-nitroso-, S(+)-; 36702-44-0; S(+)-N-Nitroso-2-methyl-piperidin [German]; S(+)-2-Methyl-N-nitrosopiperidine; S(+)-N-Nitroso-2-methyl-piperidin; DTXSID1020853; ZINC5751926; (2S)-2-methyl-1-nitroso-piperidine; LS-7509; ACM36702440; [2S,(+)]-2-Methyl-1-nitrosopiperidine; A824067; Piperidine, 2-methyl-N-nitroso-, S(+)-; S(+)-N-Nitroso-2-methyl-piperidin [German]
(2S)-2-[(Dimethoxyphosphinyl)thio]butanedioic acid, 1,4-Diethyl ester
(2S)-2-[4-(2,4-Dichlorophenoxy)phenoxy]propanoic acid
(2S)-2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy]propanoic acid ethyl ester
(2S)-N,N-Diethyl-2-(1-naphthalenyloxy)propanamide
(2S,3R,12bS)-3-Ethenyl-1,2,3,4,6,7,12,12b-octahydro-2-[[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]methyl]indolo[2,3-a]quinolizine
(2S,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Validamycin; Validamycin; VALIDAMYCIN A; 37248-47-8; Validacin; Valimon; jinggangmycin; UNII-313E9620QS; T-7545-A; CHEBI:29703; 313E9620QS; (1S-(1alpha,4alpha,5beta,6alpha))-1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol; 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydroxymethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside; D-1,5,6-Trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol; HSDB 6745; jinganmycin A; (1S-(1a,4a,5B,6a))-1,5,6-Trideoxy-3-O-B-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-d-chiro-inositol; 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside; (+)-validamycin A; Validamycin (technical); (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside; SCHEMBL3121491; CHEMBL1923413; DTXSID4058073; D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1-alpha,4-alpha,5-beta,6-alpha))-; ZINC8437016; AKOS016012982; AG-F-30599; (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; AS-15281; O743; SC-81107; TR-015151; C12112; K-8237; 248V478; Validamycin A, PESTANAL(R), analytical standard; W-204201; D-chiro-Inositol, 1,5,6-trideoxy-3-O-|A-D-glucopyranosyl-; D-Chiro-inositol,1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-; (2R,3R,4S,5S,6R)-2-((1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)cyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol; Validamycins; Solacol
(2S,3aS,5aS,6R,9aR,9bR,10R)-2-(3-Furanyl)hexahydro-6-hydroxy-6-(hydroxymethyl)-10-methyl-3aH,6H-5a,9b-propano-5H-furo[2,3-c][2]benzopyran-12-one
(2S,4R)-1-(Tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (2S,4R)-1-(1,1-Dimethylethyl)ester 4-hydroxy-1,2-pyrrolidinedicarboxylic acid; trans-1-(tert-Butoxycarbonyl)-4-hydroxy-L-proline; (2S,4R)-1-tert-Butyl 4-hydroxy-1,2-pyrrolidinecarboxylate
(2S,4R)-Difenoconazole 1-[[(2S,4R)-2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole; Difenoconazole, (2S,4R)-; UNII-75D9W6Q0SI
(2S,4aR,5R,6E,10aS,14cS)-6-Ethylidene-4a,5,6,7,8,9,10,14c-octahydro-2-hydroxy-8-methyl-4H-5,10a-ethano-3-oxa-8,14b-diazabenzo[a]cyclonon[cd]azulene-1,15(2H)-dione
(2S,4aR,5R,6E,10aS,14cS)-6-Ethylidene-4a,5,6,7,8,9,10,14c-octahydro-2-methoxy-8-methyl-4H-5,10a-ethano-3-oxa-8,14b-diazabenzo[a]cyclonon[cd]azulene-1,15(2H)-dione
(2S,5R,6R)-3,3-Dimethyl-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Penicillin; Penicillin; Cillin; Benzopenicillin; Galofak; Compocillin G; 61-33-6; (Phenylmethyl)penicillin; 3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 7005-30-3; NSC131815; (Phenylmethyl)penicillinic acid; NSC-193396; 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Penicilline G sodium salt; Oprea1_713794; Oprea1_861345; CHEMBL300052; SCHEMBL2109546; CTK2H5530; DTXSID20274362; NSC11964; NSC-11964; NSC193396; STL453455; AKOS030242685; MCULE-3899419884; NCI60_000703; SC-58301; LS-187243; WLN: T45 ANV ESTJ CMV1R& F F GVQ; 3,3-Dimethyl-6-(phenylacetylamino)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-(2-phenylacetamido)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2.alpha.,5.alpha.,6.beta.)]-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-; penicillin g; Benzylpenicillin; Benzylpenicillinic acid; Free penicillin II; Pencillin G; Benzylpenicillin G; Benzyl penicillin; Free penicillin G; Dropcillin; Gelacillin; Liquacillin; Pharmacillin; Cilopen; Pradupen; BencilpeniciliSpecilline G; Benzylpenicillinum; Cilloral; Cosmopen; Ursopen; Free benzylpenicillin; 61-33-6; Benzylpenicilline; Phenylacetamidopenicillanic acid; 6-(2-Phenylacetamido)penicillanic acid; Benzopenicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin potassium; Penicillinic acid, benzyl-; (5R,6R)-Benzylpenicillin; Penicillin, (phenylmethyl)-; Galofak; Penicillin-G potassium; Compocillin G; bensylpenicillin; benzyl benicillin; Bencilpenicilina [Spanish]; Benzylpenicilline [French]; Benzylpenicillinum [Latin]; Penicillinic acid, (phenylmethyl)-; UNII-Q42T66VG0C; Benzylpenicillin [INN:BAN]; Penicillin; PENICILLIN-2; CHEBI:18208; Sodium penicillin; HSDB 3166; EINECS 200-506-3; NSC 193396; BRN 0044740; Sodium benzylpenicillin; (Phenylmethyl)penicillin; Q42T66VG0C; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; C16H18N2O4S; (Phenylmethyl)penicillinic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-; Cillora; PenicillinG; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2alpha,5alpha,6beta)]-; PNN; SMR000538912; NSC-193396; Penicillin,(S); 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-; PENICILLIN-G; Spectrum_000933; Benzylpenicillin (INN); CHEMBL29; Prestwick0_001078; Prestwick1_001078; Prestwick2_001078; Prestwick3_001078; Spectrum2_000518; Spectrum3_000542; Spectrum4_000471; Spectrum5_001108; Epitope ID:114070; SCHEMBL3783; BSPBio_001096; BSPBio_002183; KBioGR_000942; KBioSS_001413; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-27-00-05861 (Beilstein Handbook Reference); MLS000766897; MLS001032123; MLS001173382; DivK1c_000316; SPBio_000475; SPBio_002998; BPBio1_001206; GTPL4796; DTXSID5046934; CTK2F3306; KBio1_000316; KBio2_001413; KBio2_003981; KBio2_006549; KBio3_001683; J01CE01; JGSARLDLIJGVTE-MBNYWOFBSA-N; NINDS_000316; HMS2875L09; (2S,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; ZINC3871701; BDBM50022787; Phenylacetyl-6-aminopenicillanic acid; AKOS005203091; API0003779; DB01053; IDI1_000316; NCGC00159348-02; NCGC00159348-03; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-; CC-24547; SBI-0051476.P003; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-; Bicillin (*Benzathine Salt, Tetrahydrate*); LS-149836; FT-0631271; FT-0770573; C05551; D02336; (2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]; 061P336; C-20153; Q258450; W-109262; BRD-K55191674-236-03-7; BRD-K55191674-237-02-7; BRD-K55191674-237-12-6; Benzylpenicillin, Antibiotic for Culture Media Use Only; 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid; (+)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G); (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-[(PHENYLACETYL)AMINO]-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion (Penicillin G); 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)- (8CI); 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, (2S,5R,6R)-; Penicillin G potassium; 113-98-4; Penicillin G potassium salt; Potassium benzylpenicillin; Benzylpenicillin potassium; Benzylpenicillin potassium salt; Penicillin G K; Potassium penicillin G; benzylpenicilline potassique; Potassium benzylpenicillinate; Potassium salt of benzylpenicillin; Pfizerpen G; Notaral; Penicillin G (potassium); UNII-VL775ZTH4C; Pfizerpen; PENICILLIN-2; CHEBI:7963; Penicillin potassium G, crystalline; Penicillin; VL775ZTH4C; Pentids; Penicillin G potassium [USP]; MLS000069426; 6beta-phenylacetamidopenicillanic acid potassium salt; potassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Cilloral potassium salt; Cosmopen potassium salt; Pentids '200'; SMR000059004; PENTIDS '250'; PENTIDS '400'; PENTIDS '800'; Penicillin G potassium (USP); Benzylpenicilline potassique [DCF]; EINECS 204-038-0; Novocillin vet.; NSC 131815; Penicillin G Potassium in Plastic Container; 61-33-6 (FREE ACID); penicilline; Pfizerpen (TN); AI3-50119; Penicilline G potassium; NSC-131815; Opera_ID_1649; potassium; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Epitope ID:140781; CHEMBL1223; DSSTox_CID_25106; DSSTox_RID_80673; DSSTox_GSID_45106; SCHEMBL34078; MLS001076462; SPECTRUM1500465; DTXSID7045106; HMS500P18; IYNDLOXRXUOGIU-LQDWTQKMSA-M; HMS1920F12; HMS2091N12; HMS2234C21; Benzylpenicillin potassium (JP17); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenylacetyl)amino)- (2S,5R,6R)-, potassium salt (1:1); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S,5R,6R)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-; BCP14289; Monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Potassium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Tox21_110044; CCG-39599; MFCD00036193; AKOS008145411; CS-3873; MCULE-7644229995; NCGC00014313-01; AC-14408; AS-75133; CAS-113-98-4; CC-33871; CPD000059004; E705; HY-17591; SAM002548944; AB1009476; Penicillin G potassium salt, ~1600 U/mg; FT-0603312; P1772; D01053; Penicillin G potassium salt, >=98.0% (HPLC); C-21186; W-108609; Q27089370; Penicillin G potassium salt, powder, mouse embryo tested; Z803129904; Penicillin G potassium salt, VETRANAL(TM), analytical standard; Penicillin G Potassium, Antibiotic for Culture Media Use Only; Benzylpenicillin potassium, European Pharmacopoeia (EP) Reference Standard; Penicillin G potassium salt, meets USP testing specifications, powder; Penicillin G potassium salt, powder, BioReagent, suitable for cell culture; Penicillin G potassium, United States Pharmacopeia (USP) Reference Standard; potassium 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylate; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-,monopotassium salt; Benzylpenicillin potassium salt; potassium [2S-(2|A,5|A,6|A)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Penicillin G sodium; Penicillin G sodium salt; 69-57-8; Benzylpenicillin sodium; Crystapen; American penicillin; Pencillin G sodium; Sodium penicillin G; BENZYLPENICILLIN SODIUM SALT; Sodium benzylpenicillinate; Sodium penicillin II; Mycofarm; Novocillin; Penilaryn; Veticillin; Sodium penicillin; Kesso-Pen; Pen-A-Brasive; Sodium benzylpenicillin G; Monosodium benzylpenicillin; Benzylpenicillinic acid sodium salt; Sodium benzylpenicillin; Penicillin G, sodium; Sugracillin sodium salt; Penicillin G Sodium, Crystalline; Sodium benzylpenicyllinate; UNII-YS5LY7JF4N; Penicillin-G, monosodium salt; Sodium 6-(phenylacetamido)penicillanate; EINECS 200-710-2; OK 431; YS5LY7JF4N; Penicillin; NSC 402815; Penicillin G sodium [USP]; CHEBI:51765; Penicillin G sodium (USP); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-, monosodium salt; Monosodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; PenicillinGsodiumsalt; Penicillin G sodium salt, 98%; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, monosodium salt; Sodium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; 61-33-6 (FREE ACID); Penicillin G Sodium [USAN]; NSC-402815; Penicillin G sodium (TN); CHEMBL1126; C16H17N2NaO4S; SCHEMBL34218; C16H17N2O4S.DTXSID6040581; KS-00000WAN; BIP0142; BENZYL PENICILLIN POTASSIUM; FCPVYOBCFFNJFS-LQDWTQKMSA-M; ZX-AFC000647; HMS1571G18; HMS2098G18; HMS3715G18; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2S,5R,6R)-, monosodium salt; HY-B1463; MFCD00069666; s4160; AKOS015961217; CCG-221078; CS-7971; LS-1587; CAS-69-57-8; NCGC00017015-01; Penicillin G sodium salt, ~1650 U/mg; AC-13436; E706; K162; SC-16403; Penicillin G sodium salt, 96.0-102.0%; FT-0603271; P1770; SW197252-3; D05408; P-1200; Q27122736; F0001-2583; Pencillin G sodium salt, Antibiotic for Culture Media Use Only; sodium 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylate; Benzylpenicillin sodium, European Pharmacopoeia (EP) Reference Standard; Penicillin G sodium salt, powder, BioReagent, suitable for cell culture; Penicillin G sodium, United States Pharmacopeia (USP) Reference Standard; PENICILLIN G, SODIUM SALT (ALSO SEE: 1538-09-6 BENZATHINE PEN. G); sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylate; Pfizerpen; Capicillin; Eskacillin; HiperciliSugracillin; Cintrisul; Cristapen; Falapen; Hyasorb; Hylenta; Lemopen; Liquapen; Monopen; Penalev; Penisem; Scotcil; Tabilin; Cillin; Forpen; Pentid; Tu Cillin; C-Cillin; Paclin G; Qidpen G; Megacillin tablets; SK-Penicillin G; Van-Pen-G; Pentids; Potassium benzylpenicillin G; Penicillin G, potassium salt; Penicillin; Cilloral potassium salt; Cosmopen potassium salt; Pentids '200'; Benzylpenicillinic acid potassium salt; PENTIDS '250'; PENTIDS '400'; PENTIDS '800'; Potassium 6-(phenylacetamido)penicillanate; Benzylpenicilline potassique [DCF]; Novocillin vet; EINECS 204-038-0; NSC 131815; AI3-50119; Penicillin G Potassium in Plastic Container; potassium 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; SCHEMBL6054109; Benzylpenicillin, potassium salt; Penicillin G Potassium [USAN]; C16H17N2O4S.K; CHEMBL1434858; CTK5A4315; HMS3259A18; HMS3370F17; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S,5R,6R)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, potassium salt (1:1); Monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Potassium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; MCULE-3955575945; NC00583; NCGC00094752-01; NCGC00094752-02; CPD001491654; SAM002564229; LS-149845; 55878-83-6; potassium 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Penicillin; Penicillin G Na salt; NSC-402815; Benzyl penicillin Na salt; component of Crystifor '400'; PC-B-45; NSC402815; WLN: T45 ANV ESTJ CMV1R& F1 F1 GVQ; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, monosodium salt; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2.alpha.,5.alpha.,6.beta.)]-, monosodium salt; EINECS 215-794-6
(2S2-[(Dimethoxyphosphinothioyl)thio]butanedioic acid, 1,4-Diethyl ester
(2Z,4E)-2-Chlorohexa-2,4-dienedioic acid Chloromuconic acid; 2,4-Hexadienedioic acid, chloro-
(2Z,6E)-Farnesol (2Z,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; (2Z,6E)-Farnesol; (Z,E)-Farnesol; cis,trans-Farnesol; 2-cis,6-trans-Farnesol; (2-cis,6-trans)-farnesol; 3790-71-4; UNII-SQ4TI19PXT; (Z,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; (2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; SQ4TI19PXT; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (Z,E)-; CRDAMVZIKSXKFV-PVMFERMNSA-N; (2Z,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-ol; (2-cis,6-trans)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; 3,7,11-trimethyldodeca-2Z,6E,10-trien-1-ol; Farnesyl alcohol; Farnesol, (2Z,6E)-; NSC60597; (Z)-Farnesol; cis,trans-.alpha.-Farnesol; SCHEMBL806894; CHEBI:16774; DTXSID30274196; ZINC13507234; LMPR0103010013; 2-cis,6-trans-Farnesol, >=95.0% (GC); C03220; 3,7,11-trimethyl-dodeca-2cis,6trans,10-trien-1-ol; Q27102070; UNII-EB41QIU6JL component CRDAMVZIKSXKFV-PVMFERMNSA-N; N1S; Farnesol, (2Z,6E)-; (Z,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol
(2beta,3beta,5beta,22R,24S,25S,28R)-2,3,14,20,22,28-Hexahydroxy-6-oxo-stigmast-7-en-26-oic acid gamma-lactone Cyasterone; AI3-44890
(2s,4As,6as,8ar,10s,12as,14as,14br)-10-hydroxy-2,4a,6a,9,9,12a,14a-heptamethyl-1,2,3,4,4a,5,6,6a,7,8,8a,9,10,11,12,12a,13,14,14a,14b-icosahydropicene-2-carboxylic acid Bryonolic acid; 3beta-Hydroxy-D-C-friedoolean-8-en-29-oic acid
(3-Bromophenyl)acetic acid 3-Bromophenylacetic acid; (3-Bromophenyl)acetic acid; EINECS 217-522-1
(3-Bromopropoxy)benzene 3-Bromopropylphenyl ether; Benzene, (3-bromopropoxy)-; AI3-11213
(3-Chloro-1-propynyl)cyclohexane 55723-99-4; (3-CHLORO-1-PROPYNYL)CYCLOHEXANE; (3-CHLOROPROP-1-YN-1-YL)CYCLOHEXANE; Cyclohexane, (3-chloro-1-propynyl)-; DTXSID70204270; 3-Chloro-1-cyclohexyl-1-propyne; XDPVEYOYMRUDJB-UHFFFAOYSA-N; (3-Chloro-1-propynyl)cyclohexane #; AKOS006387982; NA
(3-Chlorophenyl)carbamic acid, 1-Methylethyl ester mixt. with 1,2-dihydro-3,6-pyridazinedione
(3-Chloropropyl)trimethoxysilane 3-Chloropropyltrimethoxysilane; 2530-87-2; (3-Chloropropyl)trimethoxysilane; Silane, (3-chloropropyl)trimethoxy-; 3-Chloropropyltrimethyoxysilane; Sila-Ace S 620; CPS-M; Silane (3-chloropropyl)tris(methoxy)-; 3-chloropropyl(trimethoxy)silane; KBM 703; Chloropropyltrimethoxysilane; 3-(Trimethoxysilyl)propyl chloride; UNII-T21BNL1S7F; A 143; NSC 83878; Z 6076; SH 6076; 3-Chloropropyl trimethoxysilane; CPTMO; (3-Chloropropyl)trimethoxysilan; Trimethoxy(3-chloropropyl)silane; gamma-Chloropropyltrimethoxysilane; Silane, (chloropropyl)trimethoxy-; (gamma-Chloropropyl)trimethoxysilane; EINECS 219-787-9; T21BNL1S7F; 3-trimethoxysilylpropylchloride; 3-chloropropyl-trimethoxysilane; 3-chloropropyltrimethoxy silane; 3-Trimethoxysilylpropyl Chloride; gamma-Chloropropyl trimethoxysilane; OXYZDRAJMHGSMW-UHFFFAOYSA-N; .gamma.-Chloropropyltrimethoxysilane; MFCD00000997; (3-Chloropropyl)trimethoxysilane, 98+%; C6H15ClO3Si; Dynasylan CPTMO; Petrarch C3300; Dow corning Z-6076; DSSTox_CID_7490; ACMC-209gj3; EC 219-787-9; chloropropyl trimethoxysilane; chloropropyltrimethoxy-silane; DSSTox_RID_78470; NCIOpen2_001219; DSSTox_GSID_27490; SCHEMBL37352; trimethoxysilylpropyl chloride; KSC491G4J; (CH3O)3Si(CH2)3Cl; Cl(CH2)3Si(OCH3)3; CHEMBL3184213; DTXSID4027490; Trimethoxy-3-chloropropyl silane; CTK3J1344; KS-00000UGB; OXYZDRAJMHGSMW-UHFFFAOYSA-; 3-(chloropropyl)-trimethoxysilane; gama-chloropropyl trimethoxy silane; (3-chloropropyl)(trimethoxy)silane; 3-chloranylpropyl(trimethoxy)silane; Trimethoxy-(3-chloropropyl) silane; .delta.-Chloropropyltrimethoxysilane; NSC83878; (3-chloro-propyl)-trimethoxy-silane; Tox21_200013; ANW-25693; CC3300; NSC-83878; (.gamma.-Chloropropyl)trimethoxysilane; AKOS008901063; ZINC169743016; RTR-011572; TRA0068119; NCGC00248491-01; NCGC00257567-01; N133; (3-Chloropropyl)trimethoxysilane, >=97%; CAS-2530-87-2; DB-046667; LS-145155; TR-011572; FT-0604706; C 3300; S04675; A817776; C-36299; Q27289563; InChI=1/C6H15ClO3Si/c1-8-11(9-2,10-3)6-4-5-7/h4-6H2,1-3H3; A 143
(3-Ethoxyphenyl)urea N-3-Ethoxyphenylurea; Urea, (m-ethoxyphenyl)-; 4-13-00-00990 (Beilstein Handbook Reference)
(3-Hydroxyphenyl)carbamic acid 1-methylethyl ester
(3-Nitrobenzylidene)malononitrile [(3-Nitrophenyl)methylene]propanedinitrile; Malononitrile, (m-nitrobenzylidene)-; 2-09-00-00641 (Beilstein Handbook Reference)
(3-Phenoxyphenyl)methanol 3-Phenoxybenzenemethanol; 3-Phenoxybenzyl alcohol; (3-Phenoxyphenyl)methanol; 13826-35-2; 3-Phenoxybenzylalcohol; m-Phenoxybenzyl alcohol; Benzenemethanol, 3-phenoxy-; 3-Phenoxybenzenemethanol; 3-(Hydroxymethyl)diphenyl ether; 3-Phenoxybenzylic alcohol; UNII-04964J25DQ; BENZYL ALCOHOL, m-PHENOXY-; EINECS 237-525-1; 3-PBOH; BRN 0475312; (3-phenoxy-phenyl)-methanol; 3-Phenoxybenzyl alcohol, 98%; 1-hydroxymethyl-3-phenoxybenzene; CHEBI:62527; KGANAERDZBAECK-UHFFFAOYSA-N; MFCD00004636; 04964J25DQ; AK-58845; DSSTox_CID_7756; DSSTox_RID_78556; DSSTox_GSID_27756; (3-phenoxyphenyl)methan-1-ol; CAS-13826-35-2; 4eh7; ACMC-209chh; 3-phenoxyphenyl methanol; m-phenoxy-benzyl alcohol; 3-Phenoxylbenzyl alcohol; 3-phenoxy benzyl alcohol; 3-phenoxy-benzyl alcohol; [3-(phenoxy)phenyl]methanol; 3-06-00-04545 (Beilstein Handbook Reference); KSC389Q3F; SCHEMBL358425; (3-(phenyloxy)phenyl)methanol; CHEMBL1869836; DTXSID7027756; DAlc2-H_000047; KGANAERDZBAECK-UHFFFAOYSA-; ZINC391848; EBD18383; KS-00000NP3; ZX-AT007904; Tox21_201473; Tox21_303571; ANW-20451; DT1173; SBB063872; AKOS000249474; AS04661; CS-W015614; MCULE-7166224663; OR18354; PS-4045; RTR-005066; VZ27209; NCGC00164079-01; NCGC00164079-02; NCGC00257439-01; NCGC00259024-01; AC-10911; CC-15855; LS-43127; Q319; SC-76079; SY036130; AX8088806; DB-042421; TR-005066; FT-0616314; P0979; ST50319446; C19800; K-4476; 3-Phenoxybenzyl alcohol, purum, >=97.5% (GC); A807364; C-09462; J-007112; J-513024; Q18409953; 0OO; InChI=1/C13H12O2/c14-10-11-5-4-8-13(9-11)15-12-6-2-1-3-7-12/h1-9,14H,10H2; 3-Phenoxybenzylalcohol; 3-06-00-04545 (Beilstein Handbook Reference)
(3-Phenoxyphenyl)methyl (1R,3S)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate 3-(2,2-Dibromoethenyl)-2,2-dimethylcyclopropanecarboxylic acid (3-phenoxyphenyl)methyl ester; Cyclopropanecarboxylic acid, 3-(2,2-dibromoethenyl)-2,2-dimethyl-, (3-phenoxyphenyl)methyl ester, (1R-trans)-; NRDC 163
(3-Phenyl-2-propenylidene)propanedinitrile
(3-Trifluoromethyl-4-nitrophenol + Bayer 73
(3-exo, 5-endo, 6-exo)-2,2,3,5,6-Pentachloro-1,7,7-tris(chloromethyl)bicyclo(2.2.1)-heptane
(3As,8as)-2,2,8-trimethyl-1,2,3,3a,6,8a-hexahydroazulene-5,6-dicarbaldehyde (3a alpha, 8 beta, 8a alpha)-(-)-1,2,3,3a,8,8a-Hexahydro-2,2,8-trimethyl-5,6-azulenedicarboxaldehyde; Velleral; CCRIS 1706
(3E,5S,8R,11E,13S,16R)-5,13-Dihydroxy-8,16-dimethyl-1,9-Dioxacyclohexadeca-3,11-diene-2,10-dione
(3R,4S,5S,6R)-Rel-1,3,4,5,6-pentachlorocyclohexene 2,3,4,5,6-Pentachlorocyclohexene; 4-05-00-00234 (Beilstein Handbook Reference)
(3S)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine (gammaS)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine; Fluoxetine, (S)-; UNII-6MYD4C025Q
(3S,4R,5Ar,6R,8S,9R,9aR)-8-[[(1E,3R,8R,9R,10R,11S,14R)-9,14-dihydroxy-14-(methoxymethyl)-3,10-dimethyl-6-propan-2-yl-8-tricyclo[9.3.0.03,7]tetradeca-1,6-dienyl]oxy]-4-(hydroxymethyl)-6-(methoxymethyl)-4-methyl-3,5a,6,8,9,9a-hexahydro-2H-pyrano[3,4-b][1,4]dioxepine-3,9-diol [1(4R,5R,6R,6aS,9R,10aR),3(1R,2S)]-1,2,4,5,6,6a,7,8,9,10a-Decahydro-5,9-dihydroxy-9-(methoxymethyl)-6,10a-dimethyl-3-(1-methylethyl)dicyclopenta[a,d]cycloocten-4-yl-3,4-O-[2-hydroxy-1-(hydroxymethyl)-1-methyl-1,3-propanediyl-6-O-methyl-alpha-D-gluco//; alpha-D-Glucopyranoside, (4R,5R,6R,6aS,9R,10aR)-1,2,4,5,6,6a,7,8,9,10a-decahydro-5,9-dihydroxy-9-(methoxymethyl)-6,10a-dimethyl-3-(1-methylethyl)dicyclopenta(a,d)cycloocten-4-yl 3,4-O-((1R,2S)-2-hydroxy-1-(hydroxymethyl)-1-methyl-1,3-propanediyl)-6-O-methyl-; NA
(3S,5R,10S,13R,14R,17R)-17-[(2R)-4-(3,3-Dimethylaziridin-2-yl)butan-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol (3beta,5alpha)-23-(3,3-Dimethyl-2-aziridinyl)-4,4,14-trimethyl-24-norchol-8-en-3-ol; 24,25-Iminolanosterol; 24,25-Emls
(3S,6E)-Nerolidol (3S,6E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; NEROLIDOL; (3S,6E)-Nerolidol; 1119-38-6; UNII-O5M15I17KV; (6E)-(+)-nerolidol; O5M15I17KV; CHEBI:59958; (+)-Nerolidol; 1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, (3S,6E)-; (3s)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (S-(E))-3,7,11-Trimethyldodeca-1,6,10-trien-3-ol; [S-(E)]-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; (E)-nerolidol; Nerolidol, (6E)-(+)-; (e,s)-nerolidol; 142-50-7; 7212-44-4; EINECS 214-276-7; SCHEMBL114138; (3S,6E)-3,7,11-trimethyldodeca-1,6,10-trien-3-ol; CHEMBL1923157; DTXSID80883651; ZINC1531550; LMPR0103010005; C09704; Q27126988; (3S,6E)-3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol; UNII-C65VP6N2VX component FQTLCLSUCSAZDY-ATGUSINASA-N; UNII-FG5V0N8P2H component FQTLCLSUCSAZDY-ATGUSINASA-N; UNII-QR6IP857S6 component FQTLCLSUCSAZDY-ATGUSINASA-N; Nerolidol, (6E)-(+)-; EINECS 214-276-7
(3a alpha,4alpha,9a beta)-4-(3,4-Dimethoxyphenyl)-3a,4,9,9a-tetrahydro-6,7-dimethoxynaphtho[2,3-c]furan-1(3H)-one
(3alpha,5beta,7alpha,12alpha)-3,7,12-Tris(3-aminopropoxy)-N-octyl-cholan-24-amine hydrochloride (1:4)
(3beta)-(2E)-3-(3-Hydroxy-4-methoxyphenyl)-2-propenoate lup-20(29)-en-3-ol
(3beta)-26-Methylcholest-5-en-3-ol
(3beta,11alpha,12alpha)-3-(Acetyloxy)-11,12-epoxy-13-hydroxyoleanan-28-oic acid
(3beta,18alpha,19alpha)-Urs-20(30)-en-3-ol Taraxasterol; Isolactucerol; 1059-14-9; UNII-64SK2ERN9P; 64SK2ERN9P; 18alpha,19alpha-urs-20(30)-en-3beta-ol; taraxasterin; alpha-lactucerol; SCHEMBL222272; CHEBI:9401; HY-N1178; ZINC4027386; AKOS016009424; LMPR0106180006; AX8152404; CS-0016469; 18alpha,19betaH-Urs-20(30)-en-3beta-ol; (3beta,18alpha,19alpha)-urs-20(30)-en-3-ol; Q27108380; Urs-20(30)-en-3-ol, (3beta,18alpha,19alpha)-; Taraxasterol; Isolactucerol
(3beta,4alpha,16alpha)-3,16,23-Trihydroxyolean-12-en-28-oic acid Caulophyllogenin; Caulophyllogenin; 52936-64-8; Segetalic acid; EINECS 258-265-5; (3beta,4alpha,16alpha)-3,16,23-Trihydroxyolean-12-en-28-oic acid; (3ss,4a,16a)-3,16,23-trihydroxyolean-12-en-28-oic acid; SCHEMBL2597674; CHEMBL2386968; DTXSID40967406; ZINC31351476; 3,16,23-Trihydroxyolean-12-en-28-oic acid; 936C648; C-57740; Q27456067; 5VN; (3beta,4alpha,16alpha)-3,16,23-Trihydroxyolean-12-en-28-oic acid; EINECS 258-265-5
(3beta,5alpha)-20-(2-Piperidinyl)pregnane-3,20-diol
(3beta,5beta,22R)-3,14,20,22,25-Pentahydroxycholest-7-en-6-one
(3e,3Ar,8bs)-3-({[(2r)-4-Methyl-5-Oxo-2,5-Dihydrofuran-2-Yl]oxy}methylidene)-3,3a,4,8b-Tetrahydro-2h-Indeno[1,2-B]furan-2-One (3E,3aR,8bS)-rel-3-[[[(2R)-2,5-Dihydro-4-methyl-5-oxo-2-furanyl]oxy]methylene]-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one; 2H-Indeno(1,2-b)furan-2-one, 3-((((2R)-2,5-dihydro-4-methyl-5-oxo-2-furanyl)oxy)methylene)-3,3a,4,8b-tetrahydro-, (3E,3aR,8bS)-rel-; GR24
(4-(2-Hydroxyethoxy)phenyl)(phenyl)methanone 4-(2-Hydroxyethoxy)benzophenone; 14814-17-6; (4-(2-Hydroxyethoxy)phenyl)(phenyl)methanone; 4-(2-Hydroxyethoxy)benzophenone; [4-(2-hydroxyethoxy)phenyl](phenyl)methanone; Methanone, [4-(2-hydroxyethoxy)phenyl]phenyl-; [4-(2-hydroxyethoxy)phenyl]-phenylmethanone; Oprea1_326139; Oprea1_466844; MLS000712218; CHEMBL74930; SCHEMBL887049; CTK0E8945; DTXSID10933315; 4-(2-hydroxyethoxy)-benzophenone; PNTLMFABGCHLMN-UHFFFAOYSA-N; 2-(4-benzoylphenoxyl)ethan-1-ol; HMS2667D18; ZINC3012722; STK370940; AKOS000522129; MCULE-2761321603; 4-(2-hydroxyethoxy)phenyl phenyl ketone; AK601637; DS-19713; SMR000281985; DB-097371; ST50216638; (4-(2-Hydroxyethoxyl)phenyl)(phenyl)methanone; 4-(2-hydroxyethoxy) phenyl (phenyl) methanone; {4-[(2-Hydroxyethyl)oxy]phenyl}(phenyl)methanone; SR-01000357310; SR-01000357310-1; Methanone, (4-(2-hydroxyethoxy)phenyl)phenyl-
(4-(5-Nitro-2-furyl)thiazol-2-yl)hydrazonoacetone ACETONE[4-(5-NITRO-2-FURYL)-2-THIAZOLYL]HYDRAZONE; BRN 5409123; 18523-69-8; (4-(5-Nitro-2-furyl)thiazol-2-yl)hydrazonoacetone; 2-(2-Isopropylidenehydrazono)-4-(5-nitro-2-furyl)-thiazole; ACETONE, (4-(5-NITRO-2-FURYL)THIAZOL-2-YL)HYDRAZONE; CHEMBL259553; CTK4D8965; LS-7168; acetone[4-(5-nitro-2-furyl)-2-thiazolyl]hydrazone; Acetone [4-(5-nitro-2-furyl)-2-thiazolyl]hydrazone; Acetone [4-(5-nitro-2-furyl)thiazol-2-yl]hydrazone; acetone [5-(5-nitro-2-furyl)-1,3-thiazol-2-yl]hydrazone; 2-Propanone,2-[4-(5-nitro-2-furanyl)-2-thiazolyl]hydrazone; propan-2-one [4-(5-nitro-furan-2-yl)-thiazol-2-yl]-hydrazone; Acetone, (4-(5-nitro-2-furyl)thiazol-2-yl)hydrazone; BRN 5409123